Cartesian Therapeutics, Inc.

Direct answer

Cartesian Therapeutics, Inc. is publicly traded on NASDAQ under the ticker RNAC.

Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to the advancement and discovery of nanoparticle-based immunomodulatory drugs. These innovative therapeutics are designed to both treat and prevent a variety of human ailments. The company's leading gene therapy initiative, SEL-302, is currently undergoing Phase I clinical trials, with the goal of improving the efficacy of...

Can you invest in Cartesian Therapeutics, Inc.?

Yes. Cartesian Therapeutics, Inc. trades publicly on NASDAQ as RNAC.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Cartesian Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.